Chainlink vs Injective Staking
Side-by-side comparison of LINK and INJ staking yields, risk, and key metrics. Updated every 4 hours.
Detailed comparison
Chainlink vs Injective: which should you stake?
Injective currently offers the higher APY at 7.40% compared to Chainlink's 4.50%. That's a 2.90 percentage point difference in annual yield.
In terms of market cap, Chainlink is the larger asset at $6.10B, which generally indicates more liquidity and lower volatility risk.
Both assets can be staked through various platforms and protocols. Consider diversifying across both rather than choosing one exclusively — this spreads your risk across different networks and ecosystems.
Chainlink vs Injective — common questions
Is Chainlink or Injective better for staking?
Injective currently offers a higher staking APY at 7.40% compared to Chainlink's 4.50%. However, the best choice depends on your risk tolerance, investment horizon, and portfolio strategy.
What is the APY difference between Chainlink and Injective?
Chainlink offers 4.50% APY while Injective offers 7.40% APY — a difference of 2.90 percentage points.
Which is safer to stake: LINK or INJ?
Chainlink has a low risk rating while Injective has a medium risk rating. Lower risk typically means a more established network with stronger validator infrastructure.
Can I stake both LINK and INJ?
Yes, diversifying across multiple staking assets is a common strategy. Staking both Chainlink and Injective spreads your risk across different networks and protocols.